Q4 2024 Management View CEO Amir Schlachet reported Q4 2024 as the company's strongest quarter ever, with GMV reaching $1.71 billion, a 44% increase year-over-year, and revenues hitting $263 million, ...

Winmark reported Q4 2024 earnings below estimates, reflecting challenges and strategic shifts in its business model.

We recently compiled a list of the Top 8 Must-See AI News Updates Investors Should Not Miss. In this article, we are going to ...

At this time, I would like to welcome everyone to the Karyopharm Therapeutics fourth quarter and full year 2024 financial results conference call. There will be a question-and-answer session to follow ...

Q4 2024 Management View CEO Krish Krishnan highlighted 2024 as a strong year, driven by the continued success of the VYJUVEK launch in the U.S., which is tracking as a top-tier rare disease launch. He ...